Med-IQ
Improving Multiple Myeloma Care in a Rapidly Evolving Field
Webcast Webcast

Improving Multiple Myeloma Care in a Rapidly Evolving Field


Time to Complete:
1 Hour
Released:
4/21/17
Expires:
4/20/18
PDF:

Maximum Credits:

1.0 AMA PRA Category 1 Credit(s)
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Webcast Webcast
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.
Time to Complete:
1 Hour

Released:
4/21/17

Expires:
4/20/18

PDF:

Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)
Share on:
Webcast Webcast
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Share on:


Time to Complete:
1 Hour
Released:
4/21/17
Expires:
4/20/18
PDF:


Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)


Overview: This CME Webcast explores clinical management strategies for multiple myeloma. Experts in the field use patient cases to discuss current clinical evidence and treatment guidelines for newly diagnosed and relapsed/refractory disease, with a focus on patient-, disease-, and treatment-related factors that guide therapeutic decisions.

Faculty

Joseph Mikhael, MD, MEd, FRCPC, FACP

Professor of Medicine, Mayo College of Medicine

Associate Dean, Mayo School of Graduate Medical Education

Deputy Director of Education, Mayo Clinic Cancer Center

Mayo Clinic in Arizona

Phoenix, AZ

Noopur Raje, MD

Associate Professor of Medicine

Harvard Medical School

Director, Center for Multiple Myeloma

Massachusetts General Hospital Cancer Center

Boston, MA


Disclosure Policy

Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.


Disclosure Statement

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.  

Joseph Mikhael, MD, MEd, FRCPC, FACP
Contracted research: AbbVie Inc., Celgene Corporation, Sanofi-aventis U.S. Inc.

Noopur Raje, MD
Consulting fees/advisory boards: Amgen, Celgene Corporation, Millennium: The Takeda Oncology Company, Onyx Pharmaceuticals
Contracted research: Acetylon Pharmaceuticals, Inc., Eli Lilly and Company 

The peer reviewers and activity planners have no financial relationships to disclose.


This activity has been approved for AMA PRA Category 1 Credit™.


This activity is supported by educational grants from Celgene Corporation and Takeda Oncology.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.